Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study

NCT06905483 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

COPD
Chronic Obstructive Pulmonary Disease (COPD)
Small Airway Disease
Triple Therapy
Lung Function

Interventions

DRUG: Budesonide/Glycopyrronium/Formoterol (BGF)
DRUG: Fluticasone Furoate/Umeclidinium/Vilanterol (FUV)

Sponsor

Thammasat University